| -5.51 / -1.62%|
The 18 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals Inc have a median target of 345.00, with a high estimate of 410.00 and a low estimate of 276.00. The median estimate represents a +3.22% increase from the last price of 334.24.
The current consensus among 19 polled investment analysts is to Buy stock in Regeneron Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.